Youwen Chen
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Battery Materials 6
- Advanced Battery Materials and Technologies 6
- Co-authors
- Yuanyan Liu (15 shared papers)Cheng Lü (12 shared papers)Zhiwen Cao (8 shared papers)Yurong Song (11 shared papers)Guangzhi Liu (10 shared papers)Rui Liu (3 shared papers)Chenxi Li (3 shared papers)Jinghong Hu (2 shared papers)
- Journals
- The Journal of Organic Chemistry (2 papers)Journal of Alloys and Compounds (2 papers)Frontiers in Pharmacology (2 papers)Organic Letters (1 paper)Carbohydrate Polymers (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Youwen Chen
42 papers receiving 1.3k citations
Youwen Chen's Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 146
- Biomaterials 126
- Pharmacology 67
- Oncology 198
- Molecular Medicine 38
Countries citing papers authored by Youwen Chen
This map shows the geographic impact of Youwen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youwen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youwen Chen more than expected).
Fields of papers citing papers by Youwen Chen
This network shows the impact of papers produced by Youwen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youwen Chen. The network helps show where Youwen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Youwen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers Hit paper breakdown → | 2020 | 649 |
| 2 | 2019 | 131 | |
| 3 | 2019 | 70 | |
| 4 | 2021 | 64 | |
| 5 | 2021 | 52 | |
| 6 | 2020 | 51 | |
| 7 | 2023 | 41 | |
| 8 | 2021 | 40 | |
| 9 | Nab-paclitaxel promotes the cancer-immunity cycle as a potential immunomodulator. | 2021 | 28 |
| 10 | 2021 | 22 | |
| 11 | 2021 | 20 | |
| 12 | 2023 | 19 | |
| 13 | 2019 | 19 | |
| 14 | 2022 | 17 | |
| 15 | 2022 | 16 | |
| 16 | 2018 | 16 | |
| 17 | 2020 | 16 | |
| 18 | 2024 | 9 | |
| 19 | 2015 | 8 | |
| 20 | 2018 | 8 |
About Youwen Chen
Youwen Chen is a scholar working on Molecular Biology, Electrical and Electronic Engineering, Electronic, Optical and Magnetic Materials, Organic Chemistry and Surgery, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Advancements in Battery Materials (6 papers), Advanced Battery Materials and Technologies (6 papers), Supercapacitor Materials and Fabrication (5 papers), Natural Compounds in Disease Treatment (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced Algorithms and Applications (3 papers), Asymmetric Hydrogenation and Catalysis (2 papers) and Catalytic Processes in Materials Science (2 papers). The work is most often cited by research in Cancer Research (146 citations), Biomaterials (126 citations), Pharmacology (67 citations), Oncology (198 citations) and Molecular Medicine (38 citations). Youwen Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yuanyan Liu, Cheng Lü, Zhiwen Cao, Yurong Song, Guangzhi Liu, Rui Liu, Chenxi Li, Jinghong Hu, Wen Li and Rui Liu. Their work appears in journals such as The Journal of Organic Chemistry, Journal of Alloys and Compounds, Frontiers in Pharmacology, Organic Letters and Carbohydrate Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.